Workforce & Talent

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

Parnell's new Sevoflurane offering is more than a product line extension; it's a strategic move to become a one-stop-shop for veterinary anesthesia.

A new roadside memorial for a mother and daughter killed in 2024 is more than a tribute; it's a stark reminder of a community's grief and a province's ongoing battle.

BBH's hire of Darrell Holley isn't just a personnel move; it's a calculated bet on relationship-driven advisory for private energy firms navigating a complex future.

As the World Cup looms, NJ is betting on an AI traffic network to manage chaos. Is this a long-term infrastructure revolution or a costly fix for a party?

As Senator Bernie Sanders prepares to address AI's future, his proposals signal a radical new front in his war on inequality—one that could reshape the midterms.

Beyond the headlines, the Celeris-Mobile2CRM deal reveals a calculated move to dominate a critical niche: capturing the business conversations that live on our phones.

Zepto Life Technology's FDA Breakthrough status for a fungal test isn't just a win for patients; it's a strategic move in liquid biopsy's new frontier.

A new partnership aims to unleash an autonomous AI software engineer on the federal government's most stubborn IT challenges: its aging COBOL and mainframe systems.

Concentrix celebrates its third year on the Fortune 500, crediting its AI. We dig into the tech, the financials, and the hidden costs of this pivot.

As sophisticated identity fraud targets smaller banks, AI firm Trust Stamp provides a new model for accessible, government-backed security, leveling the playing field.

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.

Amid global uncertainty, Deerpath Capital's $452M CLO reset offers a masterclass in financial strategy, prioritizing stability for long-term investors.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

MetTel's recent Gartner recognition is more than an accolade; it's a signpost for the future of work where AI and automation manage our corporate devices.

A new AI agent from AlphaSense promises to do more than just find data—it executes complex tasks. We look at the tech, trust, and future of work.

New research reveals high-net-worth investors are abandoning traditional referrals, using AI and digital due diligence to find advisors who truly get them.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.

Richtech Robotics' new Las Vegas facility is more than a warehouse; it's a multi-million dollar bet on building the AI brains for its next-gen robots.

The AI arms race for model size is over. In Silicon Valley, a new consensus emerges: efficiency, data quality, and real-world deployment are the new frontiers.